The Scientist

» drug development and ecology

Most Recent

image: Cancer Stem Cells Really Do Exist?

Cancer Stem Cells Really Do Exist?

By | August 1, 2012

Researchers track tumors as they develop, providing more support for the idea that cells with stem-cell-like properties underlie cancer growth and recurrence.

4 Comments

image: How Green Are Your Fish?

How Green Are Your Fish?

By | August 1, 2012

Farmed salmon may have more in common with their more expensive wild-caught counterparts than consumers are led to believe.

0 Comments

Contributors

August 1, 2012

Meet some of the people featured in the August 2012 issue of The Scientist.

0 Comments

image: Life (Re)Cycle

Life (Re)Cycle

By | August 1, 2012

Death breeds life in the world’s most diverse and abundant group of animals.

4 Comments

image: Lymphatic Lines

Lymphatic Lines

By | August 1, 2012

Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.

0 Comments

image: A Scientist Emerges

A Scientist Emerges

By | August 1, 2012

At age 16, Alexandra Sourakov has her first scientific publication, on the foraging behavior of butterflies.

3 Comments

image: Stem Cell Treatment = Drug

Stem Cell Treatment = Drug

By | July 30, 2012

A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.

7 Comments

image: Tissue on Chips Galore

Tissue on Chips Galore

By | July 26, 2012

The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.

1 Comment

image: Cancer Drug Flushes Out HIV

Cancer Drug Flushes Out HIV

By | July 26, 2012

An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.

1 Comment

image: Microbial Perfume

Microbial Perfume

By | July 23, 2012

Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.

4 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech